Sex and gender differences in kidney cancer: clinical and experimental evidence
AJ Peired, R Campi, ML Angelotti, G Antonelli, C Conte… - Cancers, 2021 - mdpi.com
Simple Summary Kidney cancer is a frequent malignant tumor that accounts for
approximately 5% of all cancer incidences. It affects both males and females, but males are …
approximately 5% of all cancer incidences. It affects both males and females, but males are …
Systemic immune-inflammation index is a promising non-invasive biomarker for predicting the survival of urinary system cancers: a systematic review and meta …
X Li, L Gu, Y Chen, Y Chong, X Wang, P Guo… - Annals of …, 2021 - Taylor & Francis
Objective Systemic immune-inflammation index (SII) has been reported in numerous studies
to effectively predict the survival outcomes of urinary system cancers; however no …
to effectively predict the survival outcomes of urinary system cancers; however no …
Cancer‐associated fibroblasts in renal cell carcinoma: implication in prognosis and resistance to anti‐angiogenic therapy
D Ambrosetti, M Coutts, C Paoli, M Durand… - BJU …, 2022 - Wiley Online Library
Objectives To investigate the role of cancer‐associated fibroblasts (CAFs) in clear cell renal
cell carcinoma (ccRCC) with respect to tumour aggressiveness, metastasis development …
cell carcinoma (ccRCC) with respect to tumour aggressiveness, metastasis development …
Diagnostic and prognostic biomarkers in renal clear cell carcinoma
C Weaver, K Bin Satter, KP Richardson, LKH Tran… - Biomedicines, 2022 - mdpi.com
Renal clear cell carcinoma (ccRCC) comprises over 75% of all renal tumors and arises in
the epithelial cells of the proximal convoluted tubule. Molecularly ccRCC is characterized by …
the epithelial cells of the proximal convoluted tubule. Molecularly ccRCC is characterized by …
[HTML][HTML] Claudin-10 overexpression suppresses human clear cell renal cell carcinoma growth and metastasis by regulating ATP5O and causing mitochondrial …
W Yang, K Zhang, Z Zhang, J Zhou, L Li… - … Journal of Biological …, 2022 - ncbi.nlm.nih.gov
Our previous study has proved that down-regulation of CLDN10 (Claudin-10) in ccRCC
(clear cell renal cell carcinoma) was closely related to tumor metastasis and predicted an …
(clear cell renal cell carcinoma) was closely related to tumor metastasis and predicted an …
Comparative Analysis for the Distinction of Chromophobe Renal Cell Carcinoma from Renal Oncocytoma in Computed Tomography Imaging Using Machine Learning …
AJ Alhussaini, JD Steele, G Nabi - Cancers, 2022 - mdpi.com
Simple Summary Chromophobe renal cell carcinoma (ChRCC) is the 3rd most common
subtype of renal cell carcinoma (RCC), which is difficult to differentiate from benign renal …
subtype of renal cell carcinoma (RCC), which is difficult to differentiate from benign renal …
Healthcare disparities in interventional radiology
PS Trivedi, B Guerra, V Kumar, G Akinwande… - Journal of Vascular and …, 2022 - Elsevier
Racial, ethnic, and sex-based healthcare disparities have been documented for the past
several decades. Nonetheless, disparities remain firmly entrenched in our care delivery …
several decades. Nonetheless, disparities remain firmly entrenched in our care delivery …
Renal cancer: overdiagnosis and overtreatment
Renal cell carcinoma (RCC) accounts for approximately 4.1% of all new cancers, with a
median age at diagnosis of 64 years. In 2020, around 73,750 new cases were expected to …
median age at diagnosis of 64 years. In 2020, around 73,750 new cases were expected to …
Prognostic model for overall survival that includes the combination of platelet count and neutrophil–lymphocyte ratio within the first six weeks of sunitinib treatment for …
MT Sato, A Ida, Y Kanda, K Takano, M Ohbayashi… - BMC cancer, 2022 - Springer
Background The association between the combination of platelet count and neutrophil–
lymphocyte ratio (COP-NLR) at the time of adverse events during sunitinib treatment and …
lymphocyte ratio (COP-NLR) at the time of adverse events during sunitinib treatment and …
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy—A large, retrospective …
Background Partial nephrectomy (PN) is a challenging procedure, which can be associated
with severe complications. In consequence, the search for accurate and independent …
with severe complications. In consequence, the search for accurate and independent …